A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and ...

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in ...

MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has obstructed domestic cannabis research despite the Right To Try and the ...

New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

Dr. Michael Rezak, MD, Ph.D., DBe, is a renowned neurologist specializing in the treatment of complex movement disorders such as Parkinson's Disease, ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine ... drugs used to control the involuntary, jerky movements known as chorea, which both affect the dopamine ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...